Analyst consensus rating
Lifevantage Analyst Rating: Buy
Direct answer
Lifevantage's consensus rating is Buy.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked November 12, 2026.
Get free Lifevantage email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.72
- Average price target
- $7.00
- High price target
- $9.00
- Low price target
- $5.00
- Low target gap
- +5.9%
- Target upside
- +48.3%
- High target gap
- +90.7%
- Target range width
- 84.7%
- Consensus rating
- Buy
- Analysts
- 2
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Lifevantage?
Lifevantage has a verified Buy consensus. The same dataset has an average price target of $7.00.
How far are Lifevantage's low and high targets from the recorded price?
The low target implies +5.9%, while the high target implies +90.7%.
How many analysts are included in Lifevantage's consensus?
The verified consensus includes 2 analysts.
How is Lifevantage's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $4.72, then one is subtracted to produce +48.3%. This does not guarantee a future return.
When was Lifevantage's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.